开窗主动脉腔内修复术的长期靶血管结局
技术成功99.2%,60个月免于TVI为87.7%,一期通畅97.2%,免于靶血管内漏90.4%,免于再干预88.5%;胸腹主动脉瘤(TAAA)与既往主动脉手术与不良结局相关。
要点
- FEVAR靶血管长期表现良好,60个月免于TVI达87.7%。
- TAAA患者靶血管不稳定、内漏和再干预风险显著升高。
- 既往开放或腔内主动脉修复与靶血管不稳定及内漏相关。
核心结论
- FEVAR靶血管长期免于不良事件的比例高,支持该技术的有效性;TAAA及既往开放或腔内腹主动脉手术对结局有负面影响。
研究设计与样本
- 经扇形孔或有意未置入支架的开窗血管被排除在主要分析之外。
主要发现
- 技术成功率为99.2%,平均随访41.5±32个月。
- 60个月免于靶血管不稳定(TVI)为87.7%(标准误[SE]1.6%)。
- 60个月一期通畅率为97.2%(SE 0.7%),免于靶血管内漏为90.4%(SE 1.5%),免于再干预为88.5%(SE 1.6%)。
关键数值与推荐
- 既往腔内主动脉修复(风险比[HR]2.14,95%置信区间[CI]1.18-3.87;p=.012)和胸腹主动脉瘤(TAAA)(HR 3.3,95%CI 2.07-5.25;p<.001)与靶血管不稳定独立相关。
- Lifestream使用与一期通畅负相关(HR 3.61,95%CI 1.26-8.67;p=.019),主动脉夹层为正向预后因素(HR 0.14,95%CI 0.001-0.98;p=.047)。
- 靶血管内漏与既往开放手术修复(OSR)(HR 2.59,95%CI 1.20-5.59;p=.016)、每器械开窗数(HR 1.69,95%CI 1.06-2.71;p=.029)及TAAA(HR 3.66,95%CI 2.10-6.38;p<.001)相关。
- 再干预仅与TAAA存在相关(HR 3.43,95%CI 2.12-5.54;p<.001)。
临床怎么用
- FEVAR可用于复杂主动脉病例,但TAAA及既往开放或腔内主动脉手术患者需加强靶血管监测与再干预风险评估。
局限性
- 单中心回顾性设计可能限制结果的普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Fenestrated endovascular aortic repair (FEVAR) has been proposed as an alternative to open surgical repair (OSR) in complex aortic cases. Target vessel outcomes have shown good results, with re-interventions constituting an important FEVAR pitfall. This single centre, retrospective, observational cohort study presented the target vessel outcomes in patients treated with FEVAR in a high volume aortic centre. METHODS: Consecutive patients managed with custom made FEVAR from 2010 to 2024 were included. Vessels targeted through scallops or intentionally unstented fenestrations were excluded from the main analysis. Primary outcomes were target vessel technical success and primary patency, along with freedom from target vessel instability (TVI), endoleak, and re-intervention during follow up, all assessed using Kaplan-Meier estimates. Regression analyses were performed. RESULTS: The study included 340 patients and 1 181 target vessels. Technical success was 99.2%. The mean follow up was 41.5 ± 32 months. Freedom from TVI was 87.7% (standard error [SE] 1.6%) at 60 months. Previous endovascular aortic repair (hazard ratio [HR] 2.14, 95% confidence interval [CI] 1.18 - 3.87; p = .012) and thoraco-abdominal aortic aneurysm (TAAA) (HR 3.3, 95% CI 2.07 - 5.25; p < .001) were independently related to instability. Primary patency was 97.2% (SE 0.7%) at 60 months and was negatively associated with Lifestream use (HR 3.61, 95% CI 1.26 - 8.67; p = .019), while the presence of aortic dissection (HR 0.14, 95% CI 0.001 - 0.98; p = .047) was a positive prognostic factor. Freedom from target vessel endoleak was 90.4% (SE 1.5%) at 60 months. Endoleaks were associated with previous OSR (HR 2.59, 95% CI 1.20 - 5.59; p = .016), number of fenestrations per device (HR 1.69, 95% CI 1.06 - 2.71; p = .029), and TAAA (HR 3.66, 95% CI 2.10 - 6.38; p < .001). Freedom from re-intervention at 60 months was 88.5% (SE 1.6%); only TAAA presence was associated with re-interventions (HR 3.43, 95% CI 2.12 - 5.54; p < .001). CONCLUSION: Target vessel performance in FEVAR demonstrated high long term freedom from adverse events, highlighting the effectiveness of the technique. TAAA was found to negatively affect outcomes, as well as previous open or endovascular abdominal aortic procedures.
引用
- Apostolidis G, Nana P, Panuccio G, et al. Long Term Target Vessel Outcomes in Patients Treated with Fenestrated Endovascular Aortic Repair. Eur J Vasc Endovasc Surg. 2026. PMID: 41643929. doi:10.1016/j.ejvs.2026.01.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。